Great points, I don't see a competitor
Should be the #1 THC/CBD CPG company with $40/$50 million per Q revenue after Canada okay's edibles and drinks in late 2019.
This will put Revs on par with OrganiGram, which is heading to $10 CAD soon.
I'd say in the very least this stock has a decent pump in late 2019, early 2020 once Revs hit close to $50 million per Q.
$1 should be a baseline here.
I assume the media attention will come closer to when Canada Okay's edibles, late 2019. Could be a sleeper until then but I'm positioned.
It looks like their expansion into California alone in 4Q 2018 brought $4 million in Revenue, that's without full expansion there, so California alone could be a $10+ million+ revenue per Q market when fully expanded into...
It looks like Rev's should increase each Q from here on out.
Just depends when the MMs want to run this stock and what they set the price discovery too. With the share structure and revenues to come in the next few Qs I don't see how this doesn't have a decent run.
Have to be patient with this one, but the Revenue numbers are there and it's a hot industry.
But your points on Dixi's market position with 9 years of history sits well with their recent deal with Khiron and expansion into Latin America, looks like they could dominate that market there and growing Marijuana in Columbia with infrastructure and labor costs should still offer a good profit margin. I look forward for more details on the deal. Very promising the more I look into it.
Vincente Fox was the President of Coca Cola Latin America for years before joining Khiron.
News 
Market Data 
Discover 
